Researchers compared the efficacy between ustekinumab and vedolizumab for treating extraintestinal manifestations of inflammatory bowel disease.
All articles by Allison Nguyen
Researchers tested the effectiveness of pharmacist de-prescribing strategies for decreasing inappropriate ICU-initiated acid suppression therapy.
Publish Date
-
Latest News Your top articles for Friday
For More Personalized News -
Haymarket Medical NetworkTop Picks
- Loading...
Continuing Medical Education (CME/CE) Courses